Standard vs. extended surgery for pancreatic head cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial compares two types of surgery for people with pancreatic head cancer: the usual partial pancreatoduodenectomy (removing part of the pancreas and nearby structures) and a more extensive version that removes additional tissue. The goal is to see which approach works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with or are suspected to have pancreatic head cancer (a specific type of pancreatic cancer).
- You are scheduled to have a partial pancreatoduodenectomy (a type of pancreas surgery), even if you had chemotherapy or radiation before surgery.
- Your surgeon believes the cancer can be removed with one of the two surgery types being studied.
- You are at least 18 years old.
- During surgery, doctors confirm the cancer has not spread to distant organs or to certain lymph nodes behind the belly.
- You are not in another clinical trial that could interfere with this one, and your overall health status is good (ASA grade 3 or lower).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two approaches for patients with pancreatic or periampullary cancer that can be surgically removed: getting chemotherapy before surgery (neoadjuvant therapy) versus surgery first. It aims to find out which sequence leads to better outcomes.
This trial tests two different surgical techniques for removing pancreatic cancer tumors that can be surgically removed. Researchers want to see if operating on the main artery first leads to better outcomes than the standard approach.
This trial compares two types of surgery to remove tumors that start near the pancreas but not in it. The goal is to see if a newer, less invasive method works as well as the standard approach, which may mean fewer cuts and a faster recovery.
This trial compares two surgical strategies to help prevent return of cancer after surgery for pancreatic body and tail ductal adenocarcinoma. You may be eligible if your cancer looks removable before surgery and your overall health and lab tests are within allowed ranges.
This trial studies whether a faster, less extensive pancreatic surgery method works as well as a more traditional method for tumors in the pancreas area near the bile duct. You might be eligible if your imaging shows a tumor that can be removed with a Whipple-type operation and there is no spread to distant organs.
This study tests whether removing extra tissue around the pancreas during a standard surgery improves outlook for people with pancreatic head cancer. You may qualify if you have this type of cancer and are planning surgery without prior chemotherapy or radiation.
Hear when a new Pancreatic Cancer Resectable trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.